Usana Health Sciences (USNA)

• Market cap: $530M
• 1 day: 0.72%
• 5 days: 10.94%
• 1 month: 4.15%
• 3 months: -19.42%
• 6 months: -23.54%
• Year to date: -22.81%
• 1 year: -32.35%
• 5 years: -68.52%
• 10 years: -50.61%
• Sector: Consumer Staples
• Industry: Packaged Foods

About: Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

Employees: 1,700

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

37% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 19

4% more funds holding

Funds holding: 146 [Q3] → 152 (+6) [Q4]

2% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 47

0.95% more ownership

Funds ownership: 55.62% [Q3] → 56.57% (+0.95%) [Q4]

4% less capital invested

Capital invested by funds: $402M [Q3] → $387M (-$14.8M) [Q4]

39% less call options, than puts

Call options by funds: $50K | Put options by funds: $82K

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $36 28% upside
• Avg. target: $36 28% upside
• High target: $36 28% upside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

DA Davidson Linda Bolton Weiser 7% 1-year accuracy 7 / 94 met price target

28% upside $36

Neutral Maintained

27 Feb 2025